Close Menu

NEW YORK — Canopy Biosciences said today it has acquired biopharma services firm Core Diagnostics.

With the purchase, St. Louis, Missouri-based Canopy acquires Core's CLIA facility, from which it will provide its multi-omic immune profiling services.

Core also offers NanoString transcriptional profiling and histopathology services including immunohistochemistry (IHC) and fluorescent in situ hybridization (FISH).

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that the CDC's SARS-CoV-2 test issues reflect earlier ones it had with Zika virus testing.

NPR writes that even with thousands of new COVID-19 papers, each should be evaluated based on its own quality.

Researchers traced a gene cluster linked to COVID-19 severity to Neanderthals, the New York Times reports.

In PNAS this week: soil bacteria-derived small molecules affect centrosomal protein, microfluidics approach for capturing circulating tumor cells, and more.